Read + Share
Amedeo Smart
Independent Medical Education
Siqueira PG, Duarte HO, Moura MDC. Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer. Vaccine 2022 May 19. pii: S0264-410X(22)00633.PMID: 35610105
Email
LinkedIn
Facebook
Twitter
Privacy Policy